Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

overall survival

  • You have access
    Dynamic Changes in Absolute Lymphocyte Counts During Eribulin Therapy Are Associated With Survival Benefit
    SHOGO NAKAMOTO, MASAHIKO IKEDA, SHINICHIRO KUBO, MARI YAMAMOTO and TETSUMASA YAMASHITA
    Anticancer Research June 2021, 41 (6) 3109-3119; DOI: https://doi.org/10.21873/anticanres.15095
  • You have access
    Alpha-fetoprotein for Gastric Cancer Staging: An Essential or Redundant Tumor Marker?
    CHUN-YI TSAI, KENG-HAO LIU, CHENG-TANG CHIU, SHUN-WEN HSUEH, CHIA-YEN HUNG, JUN-TE HSU, NGAN-MING TSANG, YU-SHIN HUNG and WEN-CHI CHOU
    Anticancer Research May 2021, 41 (5) 2711-2718; DOI: https://doi.org/10.21873/anticanres.15052
  • You have access
    Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil (DCF-RT) vs. Cisplatin and 5-Fluorouracil (CF-RT) for Patients With Unresectable Locally Advanced Esophageal Cancer in a Real-world Clinical Setting
    MAKOTO SAKAI, MAKOTO SOHDA, HIDEYUKI SAITO, NOBUHIRO NAKAZAWA, YASUNARI UBUKATA, KENGO KURIYAMA, KEIGO HARA, AKIHIKO SANO, HIROOMI OGAWA, TAKEHIKO YOKOBORI, KAZUTOSHI MURATA, SHIN-EI NODA, TATSUYA OHNO, KEN SHIRABE and HIROSHI SAEKI
    Anticancer Research April 2021, 41 (4) 2141-2145; DOI: https://doi.org/10.21873/anticanres.14986
  • You have access
    Impact of Anti-angiogenic Agents on Chemotherapy Efficacy in Patients With Metastatic Colorectal Cancer: Second-line FOLFIRI Plus Bevacizumab or Aflibercept
    YUNAMI YAMADA, NOBUHISA MATSUHASHI, HIRONORI FUJII, AKITAKA MAKIYAMA, HIROTOSHI IIHARA, TAKAO TAKAHASHI, DAICHI WATANABE, SHIGERU KIYAMA, RYO KOBAYASHI, AKIO SUZUKI and KAZUHIRO YOSHIDA
    Anticancer Research January 2021, 41 (1) 533-541; DOI: https://doi.org/10.21873/anticanres.14805
  • You have access
    Cancer Cachexia Reduces the Efficacy of Nivolumab Treatment in Patients With Advanced Gastric Cancer
    HIRONORI FUJII, AKITAKA MAKIYAMA, HIROTOSHI IIHARA, NAOKI OKUMURA, SENRI YAMAMOTO, TAKEHARU IMAI, SHINICHIRO ARAKAWA, RYO KOBAYASHI, YOSHIHIRO TANAKA, KAZUHIRO YOSHIDA and AKIO SUZUKI
    Anticancer Research December 2020, 40 (12) 7067-7075; DOI: https://doi.org/10.21873/anticanres.14734
  • You have access
    Effects of Type of Antibody to EGFR and Hypomagnesemia on Overall Survival in First-line Treatment of Patients With Unresectable Advanced/Recurrent Colorectal Cancer
    MICHIO KIMURA, EISEKI USAMI and TOMOAKI YOSHIMURA
    Anticancer Research December 2020, 40 (12) 7135-7140; DOI: https://doi.org/10.21873/anticanres.14743
  • You have access
    C-Reactive Protein and Absolute Lymphocyte Count Can Predict Overall Survival of Patients Treated With Eribulin
    ATSUSHI SATA, REIKO FUKUI, YOSHIMASA MIYAGAWA, AYAKO BUN, HIROMI OZAWA, YUKIE FUJIMOTO, TOMOKO HIGUCHI, MICHIKO IMAMURA and YASUO MIYOSHI
    Anticancer Research July 2020, 40 (7) 4147-4156; DOI: https://doi.org/10.21873/anticanres.14414
  • You have access
    Induction Chemotherapy in Hypopharyngeal Cancer: Influence of DNA Repair Gene Polymorphisms
    HITOSHI HIRAKAWA, TARO IKEGAMI, SATOE AZECHI, SHINYA AGENA, JIN UEZATO, HIDETOSHI KINJYO, YUKASHI YAMASHITA, ASANORI KIYUNA, KATSUNORI TANAKA, SHUNSUKE KONDO, HIROYUKI MAEDA, MIKIO SUZUKI and AKIRA GANAHA
    Anticancer Research June 2020, 40 (6) 3277-3285; DOI: https://doi.org/10.21873/anticanres.14310
  • You have access
    Extra-cerebral Metastasis – An Independent Predictor of Survival in Older Patients With Brain Metastases Receiving a Local Therapy Plus Whole-Brain Radiotherapy (WBRT)
    DIRK RADES, TRANG NGUYEN and STEVEN E. SCHILD
    Anticancer Research May 2020, 40 (5) 2841-2845; DOI: https://doi.org/10.21873/anticanres.14258
  • You have access
    Outcomes of Laparoscopic Surgery in Colorectal Cancer Patients With Dialysis
    NOBUHIDE HIGASHINO, TAKERU MATSUDA, HIROSHI HASEGAWA, KIMIHIRO YAMASHITA, HIROKI SAKAMOTO, MASATAKA FUJIKAWA, MASASHI YAMAMOTO, SHINGO KANAJI, TARO OSHIKIRI, TETSU NAKAMURA, SATOSHI SUZUKI and YOSHIHIRO KAKEJI
    Anticancer Research April 2020, 40 (4) 2165-2170; DOI: https://doi.org/10.21873/anticanres.14176

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 11
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire